Skip to content

Enhanced Recovery After Laparoscopic Colorectal Surgery Study

Impact of Enhanced Recovery (ERAS) Protocol After Laparoscopic Colorectal Surgery Implementation on Clinical Outcomes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04091815
Enrollment
100
Registered
2019-09-17
Start date
2019-06-25
Completion date
2022-01-01
Last updated
2020-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Colorectal Surgery

Keywords

Enhanced recovery, Multimodal analgesia, Quality of life

Brief summary

The study will assess the impact on quality of care after implementation of the ERAS (Enhanced Recovery After Surgery) protocol for laparoscopic colorectal surgery in Vilnius University Hospital Santaros klinikos. The primary goal of this study is to compare efficacy of two different types of anaesthesia - general and combined (spinal and general), efficacy of multimodal analgesia in both groups, need for rescue analgetics, time to bowel movement, time to ambulation. We also aim to study overall patient satisfaction and measure health-related quality of life, from date of randomisation until the date of hospital discharge, 30 days, 3 months and 6 months post-discharge.

Detailed description

Recovery After Surgery (ERAS) protocol is a multimodal perioperative care pathway designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery, now widely accepted in laparoscopic colorectal surgery. In laparoscopic colorectal surgery, the ERAS protocol involves an accurate interview with the patient in the preoperative phase aimed at smoking and alcohol cessation, the reduction of preoperative fasting with administration of oral carbohydrates before surgery, use of intestinal preparation for selected cases only, the prophylaxis of thromboembolism, a correct antibiotic prophylaxis, the prevention of intraoperative hypothermia and hypotension, prevention of volume overload, preference for minimally invasive surgery, multimodal analgesia with reduced opioid requirements, local anaesthetics for wound infiltration, prevention of postoperative nausea and vomiting, very limited use of the nasogastric tube, early removal of the urinary catheter, multimodal analgesia to minimize opiate consumption, early postoperative mobilization and early postoperative feeding, to promote rapid recovery of gastrointestinal functions.

Interventions

OTHERType of anaesthesia

Two different types of anesthesia general vs combined (spinal and general)

Sponsors

Vilnius University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age and older. * scheduled for laparoscopic colorectal surgery. * patient informed and having accepted the principle of enhanced recovery after surgery. * patient written consent will be obtained preoperatively for eligible study participants.

Exclusion criteria

Preoperative: * patients who can not comply with the ERAS protocol because they do not understand the language or has a cognitive disorder. * patients with a documented allergy to nonsteroidal anti-inflammatory drugs and acetaminophen. * preoperative renal insufficiency (creatinine clearance less than or equal to 30ml/min) or hemodialysis. * patients with a history of hepatic impairment. * chronic pain condition that required daily opioid dependence. Operative: * conversion to laparotomy.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain intensityFrom time to PACU admission until discharge. Every 6 hour for first 24-hour, then every 12 hour until 72 hours.Number of patients with unsatisfactory pain relief evaluated with visual analogic scale (VAS \> 4, with 0-no pain, 10-worst possible pain)

Secondary

MeasureTime frameDescription
Time to bowel movementFrom time of PACU admission until the date of first documented bowel mowement, assessed 24 hours postoperatively.The times it takes for the first bowel movement after postoperative will be measured.
Time oral intakeFrom time of PACU admission until the date of first documented liquid oral intake.The time it takes to start oral liquid intake postoperatively will be measured.
Time to ambulationFrom time of PACU admission until the first documented ambulation, assessed 72 hours postoperatively.The time it takes for the patient to ambulate successfully after the surgery will be measured.
Time to urinary catheter removalFrom time of PACU admission until the date of urinary catheter removed will be measured.The time it takes to urinary catheter removal.
Time to hospital dischargeFrom the date of randomisation until the date of hospital discharge, or 30 days postoperatively hospital postoperatively will be measured.The time it takes the patient to be fully discharged from the hospital will be measured.
Total post-operative analgetics consumptionFrom time to PACU admission until 72 hours postoperativelyRescue analgesia will be given according to protocol (ketorolac, narcotics).
Readmission to the hospitalFrom the date of randomisation until 30 days postoperatively.If a patient will be readmitted to the hospital after being fully discharge, the event will be documented.
Post-operative nausea and vomitingNausea/vomiting will be evaluated from time to PACU admission until 72 hours postoperatively.Nausea will be evaluated by nausea/vomiting score 0 - 3 (0 - no nausea/vomiting, 3 - nausea/vomiting, \>3 times per day).
Post-operative pruritusFrom time to PACU admission until 72 hours postoperatively.Pruritus will be evaluated with a numerical rating scale (0-no pruritus, 10-worst possible pruritus).
Patient satisfactionFrom time to PACU admission until discharge, every 6 hours for the first 24-hour, then every 12 hours until 72 hours.Overall patient satisfaction as well as satisfaction related to pain, nausea/vomiting and itching management will be measured.This will be measured with a numerical rating scale (0-being worst possible satisfaction and 10-best satisfaction).
A measure of health status with EQ-5D-5L instrumentFrom the date of randomization until the date of hospital discharge. Then after 30 days, 3 months and 6 months post-discharge.The descriptive system to assess a patient's health-related quality of life which comprises 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). The EQ instrument VAS scale records the respondent's self-rated health on a vertical, 0-100 visual analog scale with endpoints labeled 'the best health you can imagine' and 'the worst health you can imagine'.
Incidence of surgical complicationsFrom date of randomisation until the date of hospital discharge, or 30 days postoperatively hospital postoperatively will be measured.The incidence of surgical complications will be documented.

Countries

Lithuania

Contacts

Primary ContactEgle Kontrimaviciute, MD, PhD
egle.kontrimaviciute@santa.lt0037052365264
Backup ContactAgne Jankuviene, MD
agnevasilkeviciute@gmail.com0037052365264

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026